Index by author

June 1, 1999; Volume 27,Issue 2

  1. Maes, A

    1. Nuclear cardiology, Part IV: Viability.
      L Mesotten, A Maes, A S Hambye, H Everaert, V Van den Maegdenbergh, P Franken and L Mortelmans
      Journal of Nuclear Medicine Technology June 1, 1999, 27 (2) 93-102;

  2. Mankoff, D A

    1. Technical aspects of sentinel node lymphoscintigraphy for breast cancer.
      L K Dunnwald, D A Mankoff, D R Byrd, B O Anderson, R E Moe, R S Yeung and J F Eary
      Journal of Nuclear Medicine Technology June 1, 1999, 27 (2) 106-111;

  3. Mann, A

    1. Women's health issues and nuclear medicine, Part I: Women and heart disease.
      A Mann
      Journal of Nuclear Medicine Technology June 1, 1999, 27 (2) 89-92;

  4. Maraganore, D M

    1. Quantitation of iodine-123-beta-CIT dopamine receptor uptake in a phantom model.
      L K Leong, M K O'Connor and D M Maraganore
      Journal of Nuclear Medicine Technology June 1, 1999, 27 (2) 117-122;

  5. Mccandless, B K

    1. Improved renal cortical SPECT of neonates and young infants using narrow imaging pallets.
      J A Cooper and B K McCandless
      Journal of Nuclear Medicine Technology June 1, 1999, 27 (2) 127-131;

  6. Mckay, E

    1. An assessment of the sensitivity of the Cedars-Sinai quantitative gated SPECT software to changes in the reconstruction of the short-axis slices.
      N Fredericks, P Baxter, E McKay and R Smart
      Journal of Nuclear Medicine Technology June 1, 1999, 27 (2) 123-126;

  7. Mesotten, L

    1. Nuclear cardiology, Part IV: Viability.
      L Mesotten, A Maes, A S Hambye, H Everaert, V Van den Maegdenbergh, P Franken and L Mortelmans
      Journal of Nuclear Medicine Technology June 1, 1999, 27 (2) 93-102;

  8. Moe, R E

    1. Technical aspects of sentinel node lymphoscintigraphy for breast cancer.
      L K Dunnwald, D A Mankoff, D R Byrd, B O Anderson, R E Moe, R S Yeung and J F Eary
      Journal of Nuclear Medicine Technology June 1, 1999, 27 (2) 106-111;

  9. Mortelmans, L

    1. Nuclear cardiology, Part IV: Viability.
      L Mesotten, A Maes, A S Hambye, H Everaert, V Van den Maegdenbergh, P Franken and L Mortelmans
      Journal of Nuclear Medicine Technology June 1, 1999, 27 (2) 93-102;

  10. Mulberry, W E

    1. The effects of selected antineoplastic agents on the labeling of erythrocytes with technetium-99m using the UltraTag RBC kit.
      J A Spicer, W B Hladik and W E Mulberry
      Journal of Nuclear Medicine Technology June 1, 1999, 27 (2) 132-135;
Back to top

In this issue